Olive, the automation company creating the Internet of Healthcare, has closed a $400 million funding round, bringing the company to a $4 billion valuation. The round was led by Vista Equity Partners, a leading global investment firm focused on enterprise software, data, and technology-enabled businesses, with additional investment from the Base10 Partners Advancement Initiative. As a Base10 Advancement Initiative portfolio company, Olive will contribute to scholarship and financial aid awards for America's Historically Black Colleges and Universities, which will become known as The Olive Scholarship.
This latest round of funding will allow Olive to further scale product development, reaching more healthcare providers who can use Olive's technology to drive life-changing outcomes. Olive has now secured $832 million in financing since March 2020, and $902 million since the company's inception in 2012.
"Olive is the leading force for rapid product development to better empower the humans in healthcare. She is being hired at health systems and insurance companies across the country at lightning speed," said Sean Lane, CEO of Olive. "Olive's widespread adoption as mission-critical tech makes it clear that now is the time for the healthcare industry to pull into the lead position for enterprise AI adoption."
Olive's enterprise AI is now in place at more than 900 hospitals in over 40 U.S. states, including more than 20 of the top 100 U.S. health systems. To drive true transformation Olive is leveraging network efforts as it connects healthcare, delivering constantly growing intelligence across the industry through a series of new products, as well as acquisitions and a platform that developers are able to build off of.